Synopsys Inc. filings document the regulatory record for a Nasdaq-listed engineering software company whose common stock trades under SNPS. The company’s disclosures cover operating and financial results, capital allocation actions such as stock repurchase authorizations and accelerated share repurchase agreements, and material-event reports tied to governance, executive roles, and organizational changes.
Proxy and annual meeting materials describe board elections, shareholder voting matters, executive compensation, equity incentive plan approvals, and corporate governance practices. Recent Form 8-K filings also document restructuring actions following the completed Ansys acquisition, amendments to prior governance disclosures, registered common stock details, exhibits, and risk-oriented statements associated with forward-looking business actions.
Synopsys Inc ownership disclosure: Vanguard Capital Management reports 14,343,552 shares of Common Stock, representing 7.48% of the class as of 03/31/2026. The filing states Vanguard has sole voting power over 1,900,654 shares and sole dispositive power over 14,343,552 shares. The Schedule 13G is signed by Ashley Grim on 04/30/2026.
Synopsys, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on April 16, 2026. Stockholders approved an Amended and Restated Equity Incentive Plan that now allows non-employee directors, as well as executive officers, to receive equity awards.
They also re-elected ten directors, approved on an advisory basis the compensation of named executive officers, and ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending October 31, 2026. A stockholder proposal to permit action by written consent did not receive sufficient support.
Vijayaraghavan Ravi K reported acquisition or exercise transactions in this Form 4 filing.
Synopsys Inc. director Vijayaraghavan Ravi K received an automatic stock award of 453 shares of common stock as a grant under the Amended and Restated Equity Incentive Plan. After this award, he directly holds 3,667 shares.
The shares subject to the award will vest on the date immediately preceding the first Annual Meeting following the grant date, provided he continues serving on the Board through that date.
Shimer Peter A reported acquisition or exercise transactions in this Form 4 filing.
Synopsys Inc. director Peter A. Shimer received a grant of 453 shares of common stock as an equity award. The shares were awarded at a stated price of $0.00 per share under an automatic grant from the company’s Amended and Restated Equity Incentive Plan.
These award shares will vest on the date immediately preceding the first Annual Meeting following the grant date, provided he continues Board service through that date. After this award, he directly holds a total of 1,378 shares of Synopsys common stock.
SCHWARZ JOHN reported acquisition or exercise transactions in this Form 4 filing.
Synopsys Inc. director John Schwarz received a grant of 453 shares of common stock as equity compensation. The award was granted at no cash cost per share and increased his directly held stake to 13,240 shares. According to the terms, the shares will vest on the date immediately preceding the first Annual Meeting following the grant date, as long as he continues to serve on the board until that time. The grant was made as an automatic award under Synopsys’ Amended and Restated Equity Incentive Plan.
Sargent Jeannine P reported acquisition or exercise transactions in this Form 4 filing.
SYNOPSYS INC director Jeannine P. Sargent received a stock award of 453 shares of Common Stock as board compensation. The award was granted at no cash cost on April 16, 2026 and will vest on the date immediately preceding the first Annual Meeting following the grant, if she continues serving on the board.
After this grant, she holds 2,997 shares directly. A separate line in the filing shows an additional 445 shares held indirectly by a Family Trust. The filing reflects routine equity compensation rather than an open-market stock purchase or sale.
PAINTER ROBERT G reported acquisition or exercise transactions in this Form 4 filing.
SYNOPSYS INC director Robert G. Painter received an equity award of 453 shares of Common Stock as compensation. The shares were granted at a price of $0.00 per share and are scheduled to vest on the date immediately preceding the first Annual Meeting following the grant, contingent on his continued Board service. Following this award, he directly holds 2,744 shares of Synopsys common stock.
JOHNSON MERCEDES reported acquisition or exercise transactions in this Form 4 filing.
Synopsys director Mercedes Johnson reported receiving an automatic award of 453 shares of common stock, granted at no cost under the company’s Amended and Restated Equity Incentive Plan. These shares will vest on the date immediately preceding the first Annual Meeting following the grant date, assuming continued Board service.
Johnson also reported an internal transfer of 491 previously directly held shares into the Mercedes Johnson Trust, bringing her indirectly held position through the trust to 2,390 shares. This transfer is disclosed as exempt from Section 16 under Rule 16a-13.
CHIZEN BRUCE R reported acquisition or exercise transactions in this Form 4 filing.
Synopsys Inc. director Bruce R. Chizen received an automatic equity award of 453 shares of Common Stock of Synopsys Inc. The shares were granted at a stated price of $0.0000 per share as a compensation award, not an open‑market purchase.
According to the award terms, the shares will vest on the date immediately preceding the first Annual Meeting following the grant date, provided he continues serving on the Board through that date. Following this grant, Chizen directly holds 16,162 shares of Synopsys common stock.
CHAFFIN JANICE reported acquisition or exercise transactions in this Form 4 filing.
Synopsys Inc. director Janice Chaffin received a stock award of 453 shares of common stock. The grant was made at a price of $0.00 per share as a compensation award rather than a market purchase. After this award, she directly holds 15,622 Synopsys shares.
The footnotes explain that the shares subject to this award will vest on the date immediately preceding the first Annual Meeting following the grant date, provided she continues to serve on the Board through that time. The award was granted automatically under Synopsys’ Amended and Restated Equity Incentive Plan.